Top

World Journal of Surgery

Published in:

01-03-2012

No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy

Authors: Shintaro Kuroda, Hirotaka Tashiro, Tsuyoshi Kobayashi, Akihiko Oshita, Hironobu Amano, Hideki Ohdan

Published in: World Journal of Surgery | Issue 3/2012

Abstract

Background

Although several studies have shown that perioperative blood transfusion is a poor prognostic factor of outcome after hepatectomy for hepatocellular carcinoma (HCC), the impact of perioperative blood transfusion on the prognosis of HCC remains unknown.

Methods

Data from 835 patients (76 transfused patients and 759 nontransfused patients) who underwent curative hepatectomy for HCC were retrospectively collected and analyzed. To overcome bias due to the different distribution of covariates for the two groups, a one-to-one match was created using propensity score analysis. After matching, patient outcomes were analyzed.

Results

After one-to-one matching, 60 transfused patients and 60 nontransfused patients had the same preoperative and operative characteristics (excluding operative blood loss). Although the morbidity rate of hepatectomy was significantly higher in the transfused group than in the nontransfused group (P = 0.016), there was no significant difference in mortality rate (P = 0.242). Additionally, the overall survival rate of transfused patients was similar to that of nontransfused patients (P = 0.466), and the difference in disease-free survival rate between the two groups was insignificant (P = 0.621).

Conclusions

Perioperative blood transfusion did not influence the overall and disease-free survival rate in the HCC patients studied. Perioperative blood transfusion may not be considered a poor prognostic factor for patients with HCC.

Poon RT, Fan ST, Lo CM et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1,222 consecutive patients from a prospective database. Ann Surg 240:698–708 discussion 708-710PubMed

Kooby DA, Stockman J, Ben-Porat L et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–869 discussion 869-870PubMed

Yamamoto J, Kosuge T, Takayama T et al (1994) Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115:303–309PubMed

Fan ST, Ng IO, Poon RT et al (1999) Hepatectomy for hepatocellular carcinoma: the surgeon’s role in long-term survival. Arch Surg 134:1124–1130PubMedCrossRef

Asahara T, Katayama K, Itamoto T et al (1999) Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23:676–680. doi:10.1007/PL00012367 PubMedCrossRef

Makino Y, Yamanoi A, Kimoto T et al (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95:1294–1300PubMedCrossRef

Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24PubMedCrossRef

Hanazaki K, Kajikawa S, Shimozawa N et al (2005) Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 52:524–529PubMed

Sugita S, Sasaki A, Iwaki K et al (2008) Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol 34:339–345PubMedCrossRef

10.

Kwon AH, Matsui Y, Kamiyama Y (2001) Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 91:771–778PubMedCrossRef

11.

Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef

12.

Itamoto T, Katayama K, Nakahara H et al (2003) Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg 90:23–28PubMedCrossRef

13.

Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef

14.

Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef

15.

Zinsmeister AR, Connor JT (2008) Ten common statistical errors and how to avoid them. Am J Gastroenterol 103:262–266PubMedCrossRef

16.

Layer P, Zinsmeister AR, DiMagno EP (1986) Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 91:41–48PubMed

17.

Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127:757–763PubMed

18.

D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281PubMedCrossRef

19.

Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990 s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMedCrossRef

20.

Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406 discussion 406-397PubMedCrossRef

21.

Herberman RB (1984) Natural killer cells and their possible roles in host resistance against tumors. Transpl Proc 16:476–478

22.

Hanna N, Fidler IJ (1980) Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65:801–809PubMed

23.

Kaplan J, Sarnaik S, Gitlin J et al (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308–310PubMed

24.

Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623PubMedCrossRef

Title: No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy
Authors: Shintaro Kuroda
Hirotaka Tashiro
Tsuyoshi Kobayashi
Akihiko Oshita
Hironobu Amano
Hideki Ohdan
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 3/2012
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-012-1425-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2012

Lymph Node Recurrence in Patients With N1b Papillary Thyroid Carcinoma Who Underwent Unilateral Therapeutic Modified Radical Neck Dissection

Log Odds of Positive Lymph Nodes in Colon Cancer: A Meaningful Ratio-based Lymph Node Classification System

Enterocutaneous Fistulas and a Hostile Abdomen: Reoperative Surgical Approaches

How to Manage Thyroid Nodules With Two Consecutive Non-Diagnostic Results on Ultrasonography-Guided Fine-Needle Aspiration

Erratum to: Single-Photon-Emission Computed Tomography (SPECT) with Technetium-99m Sestamibi in the Diagnosis of Small Breast Cancer and Axillary Lymph Node Involvement

Fungating Thyroid Cancer: A Complex Clinical Scenario